Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Heart Failure

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 371 articles:
HTML format



Single Articles


    January 2021
  1. ISHAK WW, Korouri S, Darwish T, Vanle B, et al
    Personalized treatments for depressive symptoms in patients with advanced heart failure: A pragmatic randomized controlled trial.
    PLoS One. 2021;16:e0244453.
    PubMed     Abstract available


  2. LU XH, Liu A, Fuh SC, Lian Y, et al
    Recurrent disease progression networks for modelling risk trajectory of heart failure.
    PLoS One. 2021;16:e0245177.
    PubMed     Abstract available


  3. YAMAZAKI R, Nishiyama O, Yoshikawa K, Saeki S, et al
    HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure.
    PLoS One. 2021;16:e0245778.
    PubMed     Abstract available


  4. ALHABIB KF, Gamra H, Almahmeed W, Hammoudeh A, et al
    Correction: Acute Myocardial Infarction and Acute Heart Failure in the Middle East and North Africa: Study Design and Pilot Phase Study Results from the PEACE MENA Registry.
    PLoS One. 2021;16:e0246036.
    PubMed     Abstract available


  5. KAMATH DY, Bhuvana KB, Salazar LJ, Varghese K, et al
    A qualitative, grounded theory exploration of the determinants of self-care behavior among Indian patients with a lived experience of chronic heart failure.
    PLoS One. 2021;16:e0245659.
    PubMed     Abstract available


  6. OGUNTADE AS, Ajayi IO
    Risk factors of heart failure among patients with hypertension attending a tertiary hospital in Ibadan, Nigeria: The RISK-HHF case-control study.
    PLoS One. 2021;16:e0245734.
    PubMed     Abstract available


  7. DE MARIA B, Dalla Vecchia LA, Maestri R, Pinna GD, et al
    Lack of association between heart period variability asymmetry and respiratory sinus arrhythmia in healthy and chronic heart failure individuals.
    PLoS One. 2021;16:e0247145.
    PubMed     Abstract available


  8. FUNAMIZU T, Nagatomo Y, Saji M, Iguchi N, et al
    Low muscle mass assessed by psoas muscle area is associated with clinical adverse events in elderly patients with heart failure.
    PLoS One. 2021;16:e0247140.
    PubMed     Abstract available


  9. YOLA IM, Oh A, Mitchell GF, O'Connor G, et al
    Association of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study.
    PLoS One. 2021;16:e0246355.
    PubMed     Abstract available


  10. PIERCE JB, Shah NS, Petito LC, Pool L, et al
    Trends in heart failure-related cardiovascular mortality in rural versus urban United States counties, 2011-2018: A cross-sectional study.
    PLoS One. 2021;16:e0246813.
    PubMed     Abstract available


  11. IBE T, Wada H, Sakakura K, Ugata Y, et al
    Combined pre- and post-capillary pulmonary hypertension: The clinical implications for patients with heart failure.
    PLoS One. 2021;16:e0247987.
    PubMed     Abstract available


  12. MCHORNEY CA, Mansukhani SG, Anatchkova M, Taylor N, et al
    The impact of heart failure on patients and caregivers: A qualitative study.
    PLoS One. 2021;16:e0248240.
    PubMed     Abstract available


  13. PUWANANT S, Sinphurmsukskul S, Krailak L, Nakaviroj P, et al
    The impact of the coronavirus disease and Tele-Heart Failure Clinic on cardiovascular mortality and heart failure hospitalization in ambulatory patients with heart failure.
    PLoS One. 2021;16:e0249043.
    PubMed     Abstract available


  14. KAWADA K, Fukuda H, Kubo T, Ohta T, et al
    Added value of anxiolytic benzodiazepines in predictive models on severe delirium in patients with acute decompensated heart failure: A retrospective analysis.
    PLoS One. 2021;16:e0250372.
    PubMed     Abstract available


  15. BAMFORTH RJ, Chhibba R, Ferguson TW, Sabourin J, et al
    Strategies to prevent hospital readmission and death in patients with chronic heart failure, chronic obstructive pulmonary disease, and chronic kidney disease: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0249542.
    PubMed     Abstract available


  16. ABE D, Inomata T
    Actual state of "triple therapy" for heart failure patients in eight regions of Japan: An analysis of a nationwide medical claims database.
    PLoS One. 2021;16:e0249711.
    PubMed     Abstract available


  17. MBOTWA JL, Kamps M, Baxter PD, Ellison GTH, et al
    Latent class regression improves the predictive acuity and clinical utility of survival prognostication amongst chronic heart failure patients.
    PLoS One. 2021;16:e0243674.
    PubMed     Abstract available


  18. LUPON J, Santiago-Vacas E, Cediel G, Codina P, et al
    Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?
    PLoS One. 2021;16:e0249674.
    PubMed     Abstract available


  19. KANDA M, Tateishi K, Nakagomi A, Iwahana T, et al
    Association between early intensive care or coronary care unit admission and post-discharge performance of activities of daily living in patients with acute decompensated heart failure.
    PLoS One. 2021;16:e0251505.
    PubMed     Abstract available


  20. PONGIGLIONE B, Torbica A, Gale CP, Tavazzi L, et al
    Patient, hospital and country-level risk factors of all-cause mortality among patients with chronic heart failure: Prospective international cohort study.
    PLoS One. 2021;16:e0250931.
    PubMed     Abstract available


  21. ALGUREN B, Jernberg T, Vasko P, Selb M, et al
    Content comparison and person-centeredness of standards for quality improvement in cardiovascular health care.
    PLoS One. 2021;16:e0244874.
    PubMed     Abstract available


  22. ABID L, Charfeddine S, Kammoun I, Ben Halima M, et al
    Epidemiology of heart failure and long-term follow-up outcomes in a north-African population: Results from the NAtional TUnisian REgistry of Heart Failure (NATURE-HF).
    PLoS One. 2021;16:e0251658.
    PubMed     Abstract available


  23. CHOU YY, Ward JL, Barron LZ, Murphy SD, et al
    Focused ultrasound of the caudal vena cava in dogs with cavitary effusions or congestive heart failure: A prospective, observational study.
    PLoS One. 2021;16:e0252544.
    PubMed     Abstract available


  24. TAKAHASHI S, Tanno K, Yonekura Y, Ohsawa M, et al
    Low educational level increases functional disability risk subsequent to heart failure in Japan: On behalf of the Iwate KENCO study group.
    PLoS One. 2021;16:e0253017.
    PubMed     Abstract available


  25. MAHESRI M, Chin K, Kumar A, Barve A, et al
    External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure.
    PLoS One. 2021;16:e0252903.
    PubMed     Abstract available


  26. IBE T, Wada H, Sakakura K, Ugata Y, et al
    Cardiac index predicts long-term outcomes in patients with heart failure.
    PLoS One. 2021;16:e0252833.
    PubMed     Abstract available


  27. KATO M, Mori Y, Watanabe D, Onoda H, et al
    Relationship between average daily rehabilitation time and decline in instrumental activity of daily living among older patients with heart failure: A preliminary analysis of a multicenter cohort study, SURUGA-CARE.
    PLoS One. 2021;16:e0254128.
    PubMed     Abstract available


  28. KAWASE Y, Kato T, Morimoto T, Hata R, et al
    Admission systolic blood pressure as a prognostic predictor of acute decompensated heart failure: A report from the KCHF registry.
    PLoS One. 2021;16:e0253999.
    PubMed     Abstract available


  29. TANIGUCHI C, Seto N, Shimizu Y
    Outpatient nursing support for self-monitoring in patients with chronic heart failure.
    PLoS One. 2021;16:e0254019.
    PubMed     Abstract available


  30. HAMO CE, Abdelmoneim SS, Han SY, Chandy E, et al
    OUTpatient intravenous LASix Trial in reducing hospitalization for acute decompensated heart failure (OUTLAST).
    PLoS One. 2021;16:e0253014.
    PubMed     Abstract available


  31. GOLAND S, Volodarsky I, Fabricant Y, Livschitz S, et al
    Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction.
    PLoS One. 2021;16:e0254104.
    PubMed     Abstract available


  32. CHO JH, Leong D, Cuk N, Ebinger JE, et al
    Delayed repolarization and ventricular tachycardia in patients with heart failure and preserved ejection fraction.
    PLoS One. 2021;16:e0254641.
    PubMed     Abstract available


  33. PRATTIPATI S, Sakita FM, Kweka GL, Tarimo TG, et al
    Heart failure care and outcomes in a Tanzanian emergency department: A prospective observational study.
    PLoS One. 2021;16:e0254609.
    PubMed     Abstract available


  34. LOKAJ P, Spinar J, Spinarova L, Malek F, et al
    Prognostic value of high-sensitivity cardiac troponin I in heart failure patients with mid-range and reduced ejection fraction.
    PLoS One. 2021;16:e0255271.
    PubMed     Abstract available


  35. CHOI YJ, Park JY, Lee HS, Suh J, et al
    Variable effects of underlying diseases on the prognosis of patients with COVID-19.
    PLoS One. 2021;16:e0254258.
    PubMed     Abstract available


  36. LI CX, Liang S, Gao L, Liu H, et al
    Cardiovascular outcomes associated with SGLT-2 inhibitors versus other glucose-lowering drugs in patients with type 2 diabetes: A real-world systematic review and meta-analysis.
    PLoS One. 2021;16:e0244689.
    PubMed     Abstract available


    January 2020
  37. LUND A, Nordrehaug JE, Slettom G, Hafstad Solvang SE, et al
    Plasma kynurenines and prognosis in patients with heart failure.
    PLoS One. 2020;15:e0227365.
    PubMed     Abstract available


  38. THOMSON P, Howie K, Leslie SJ, Angus NJ, et al
    Evaluating emotional distress and health-related quality of life in patients with heart failure and their family caregivers: Testing dyadic dynamics using the Actor-Partner Interdependence Model.
    PLoS One. 2020;15:e0227129.
    PubMed     Abstract available


  39. MI-MI L, Farman GP, Mayfield RM, Strom J, et al
    In vivo elongation of thin filaments results in heart failure.
    PLoS One. 2020;15:e0226138.
    PubMed     Abstract available


  40. DI TANNA GL, Wirtz H, Burrows KL, Globe G, et al
    Evaluating risk prediction models for adults with heart failure: A systematic literature review.
    PLoS One. 2020;15:e0224135.
    PubMed     Abstract available


  41. MARTINS MATIAS A, Murucci Coelho P, Bermond Marques V, Dos Santos L, et al
    Hypercaloric diet models do not develop heart failure, but the excess sucrose promotes contractility dysfunction.
    PLoS One. 2020;15:e0228860.
    PubMed     Abstract available


  42. LUND A, Nordrehaug JE, Slettom G, Solvang SH, et al
    Correction: Plasma kynurenines and prognosis in patients with heart failure.
    PLoS One. 2020;15:e0230056.
    PubMed     Abstract available


  43. STOCKIGT F, Eichhorn L, Beiert T, Knappe V, et al
    Heart failure after pressure overload in autosomal-dominant desminopathies: Lessons from heterozygous DES-p.R349P knock-in mice.
    PLoS One. 2020;15:e0228913.
    PubMed     Abstract available


  44. BRANDT EJ, Ross JS, Grady JN, Ahmad T, et al
    Impact of left ventricular assist devices and heart transplants on acute myocardial infarction and heart failure mortality and readmission measures.
    PLoS One. 2020;15:e0230734.
    PubMed     Abstract available


  45. FORRESTER SJ, Dolmatova EV, Griendling KK
    An acceleration in hypertension-related mortality for middle-aged and older Americans, 1999-2016: An observational study.
    PLoS One. 2020;15:e0225207.
    PubMed     Abstract available


  46. DI ACHILLE P, Parikh J, Khamzin S, Solovyova O, et al
    Model order reduction for left ventricular mechanics via congruency training.
    PLoS One. 2020;15:e0219876.
    PubMed     Abstract available


  47. VELAGALETI RS, Short MI, Larson MG, Vasan RS, et al
    Prognosis of "pre-heart failure" clinical phenotypes.
    PLoS One. 2020;15:e0231254.
    PubMed     Abstract available


  48. ROY B, Wolf JRLM, Carlson MD, Akkermans R, et al
    An international comparison of factors affecting quality of life among patients with congestive heart failure: A cross-sectional study.
    PLoS One. 2020;15:e0231346.
    PubMed     Abstract available


  49. JANKOWSKA-POLANSKA B, Swiatoniowska-Lonc N, Slawuta A, Krowczynska D, et al
    Patient-Reported Compliance in older age patients with chronic heart failure.
    PLoS One. 2020;15:e0231076.
    PubMed     Abstract available


  50. MOON I, Lee SY, Kim HK, Han KD, et al
    Trends of the prevalence and incidence of hypertrophic cardiomyopathy in Korea: A nationwide population-based cohort study.
    PLoS One. 2020;15:e0227012.
    PubMed     Abstract available


  51. KANAGALA P, Arnold JR, Singh A, Chan DCS, et al
    Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
    PLoS One. 2020;15:e0232280.
    PubMed     Abstract available


  52. LUISO D, Villanueva JA, Belarte-Tornero LC, Fort A, et al
    Surface respiratory electromyography and dyspnea in acute heart failure patients.
    PLoS One. 2020;15:e0232225.
    PubMed     Abstract available


  53. NGUYEN ITN, Brandt MM, van de Wouw J, van Drie RWA, et al
    Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction.
    PLoS One. 2020;15:e0232399.
    PubMed     Abstract available


  54. CLAUSS S, Schuttler D, Bleyer C, Vlcek J, et al
    Characterization of a porcine model of atrial arrhythmogenicity in the context of ischaemic heart failure.
    PLoS One. 2020;15:e0232374.
    PubMed     Abstract available


  55. GUYOT P, Djermoune EH, Chenuel B, Bastogne T, et al
    A signal demodulation-based method for the early detection of Cheyne-Stokes respiration.
    PLoS One. 2020;15:e0221191.
    PubMed     Abstract available


  56. JORBA G, Aguirre-Plans J, Junet V, Segu-Verges C, et al
    In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan.
    PLoS One. 2020;15:e0228926.
    PubMed     Abstract available


  57. OTANI K, Higa Y, Kitano T, Nabeshima Y, et al
    Prediction of cardiac events using fully automated GLS and BNP titers in patients with known or suspected heart failure.
    PLoS One. 2020;15:e0234294.
    PubMed     Abstract available


  58. YOSHIOKA K, Matsue Y, Okumura T, Kida K, et al
    Impact of brain natriuretic peptide reduction on the worsening renal function in patients with acute heart failure.
    PLoS One. 2020;15:e0235493.
    PubMed     Abstract available


  59. ONUSKO E, McDermott MR, Robbins N, Liu G, et al
    Probenecid treatment improves outcomes in a novel mouse model of peripartum cardiomyopathy.
    PLoS One. 2020;15:e0230386.
    PubMed     Abstract available


  60. GROSS C, Fresiello L, Schloglhofer T, Dimitrov K, et al
    Hemodynamic exercise responses with a continuous-flow left ventricular assist device: Comparison of patients' response and cardiorespiratory simulations.
    PLoS One. 2020;15:e0229688.
    PubMed     Abstract available


  61. HARDT F, Becker M, Brandenburg V, Grebe J, et al
    Impact of epicardial adipose tissue volume upon left ventricular dysfunction in patients with mild-to-moderate aortic stenosis: A post-hoc analysis.
    PLoS One. 2020;15:e0229636.
    PubMed     Abstract available


  62. DI TANNA GL, Wirtz H, Burrows KL, Globe G, et al
    Correction: Evaluating risk prediction models for adults with heart failure: A systematic literature review.
    PLoS One. 2020;15:e0235970.
    PubMed     Abstract available


  63. PIEROBON A, Granata N, Torlaschi V, Vailati C, et al
    Psychomotor speed as a predictor of functional status in older chronic heart failure (CHF) patients attending cardiac rehabilitation.
    PLoS One. 2020;15:e0235570.
    PubMed     Abstract available


  64. LOOP MS, Van Dyke MK, Chen L, Brown TM, et al
    Evidence-based beta blocker use associated with lower heart failure readmission and mortality, but not all-cause readmission, among Medicare beneficiaries hospitalized for heart failure with reduced ejection fraction.
    PLoS One. 2020;15:e0233161.
    PubMed     Abstract available


  65. HUANG WM, Feng JY, Cheng HM, Chen SZ, et al
    The role of pulmonary function in patients with heart failure and preserved ejection fraction: Looking beyond chronic obstructive pulmonary disease.
    PLoS One. 2020;15:e0235152.
    PubMed     Abstract available


  66. GOTO T, Miyagawa S, Tamai K, Matsuura R, et al
    High-mobility group box 1 fragment suppresses adverse post-infarction remodeling by recruiting PDGFRalpha-positive bone marrow cells.
    PLoS One. 2020;15:e0230392.
    PubMed     Abstract available


  67. ALHABIB KF, Gamra H, Almahmeed W, Hammoudeh A, et al
    Acute myocardial infarction and acute heart failure in the Middle East and North Africa: Study design and pilot phase study results from the PEACE MENA registry.
    PLoS One. 2020;15:e0236292.
    PubMed     Abstract available


  68. CABRERA-AGUILERA I, Falcones B, Calvo-Fernandez A, Benito B, et al
    The conventional isoproterenol-induced heart failure model does not consistently mimic the diaphragmatic dysfunction observed in patients.
    PLoS One. 2020;15:e0236923.
    PubMed     Abstract available


  69. PAULUS MG, Meindl C, Bohm L, Holzapfel M, et al
    Predictors of functional improvement in the short term after MitraClip implantation in patients with secondary mitral regurgitation.
    PLoS One. 2020;15:e0232817.
    PubMed     Abstract available


  70. TAMAMURA Y, Matsuura M, Shiba S, Nishikimi T, et al
    Heart failure assessed based on plasma B-type natriuretic peptide (BNP) levels negatively impacts activity of daily living in patients with hip fracture.
    PLoS One. 2020;15:e0237387.
    PubMed     Abstract available


  71. SEID E, Engidawork E, Alebachew M, Mekonnen D, et al
    Evaluation of drug therapy problems, medication adherence and treatment satisfaction among heart failure patients on follow-up at a tertiary care hospital in Ethiopia.
    PLoS One. 2020;15:e0237781.
    PubMed     Abstract available


  72. GARCIMARTIN P, Comin-Colet J, Pardo-Cladellas Y, Badosa N, et al
    Validation of the Spanish version of the questionnaire on Patient Empowerment in Long-Term Conditions.
    PLoS One. 2020;15:e0233338.
    PubMed     Abstract available


  73. MEINDL C, Hochadel M, Frankenstein L, Bruder O, et al
    The role of diabetes in cardiomyopathies of different etiologies-Characteristics and 1-year follow-up results of the EVITA-HF registry.
    PLoS One. 2020;15:e0234260.
    PubMed     Abstract available


  74. SAILLARD C, Mallet D, Chow-Chine L, Bisbal M, et al
    Non-invasive ventilation indication for critically ill cancer patients admitted to the intensive care unit for acute respiratory failure (ARF) with associated cardiac dysfunction: Results from an observational study.
    PLoS One. 2020;15:e0234495.
    PubMed     Abstract available


  75. KIM J, Choi J, Shin MS, Kim M, et al
    Do advance directive attitudes and perceived susceptibility and end-of-life life-sustaining treatment preferences between patients with heart failure and cancer differ?
    PLoS One. 2020;15:e0238567.
    PubMed     Abstract available


  76. STROCCHI M, Augustin CM, Gsell MAF, Karabelas E, et al
    A publicly available virtual cohort of four-chamber heart meshes for cardiac electro-mechanics simulations.
    PLoS One. 2020;15:e0235145.
    PubMed     Abstract available


  77. IWAMIYA T, Segard BD, Matsuoka Y, Imamura T, et al
    Human cardiac fibroblasts expressing VCAM1 improve heart function in postinfarct heart failure rat models by stimulating lymphangiogenesis.
    PLoS One. 2020;15:e0237810.
    PubMed     Abstract available


  78. YOSHIKAWA Y, Tamaki Y, Morimoto T, Yaku H, et al
    Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF Registry.
    PLoS One. 2020;15:e0239100.
    PubMed     Abstract available


  79. FRESIELLO L, Jacobs S, Timmermans P, Buys R, et al
    Limiting factors of peak and submaximal exercise capacity in LVAD patients.
    PLoS One. 2020;15:e0235684.
    PubMed     Abstract available


  80. OKA SI, Sabry AD, Horiuchi AK, Cawley KM, et al
    Perm1 regulates cardiac energetics as a downstream target of the histone methyltransferase Smyd1.
    PLoS One. 2020;15:e0234913.
    PubMed     Abstract available


  81. MIN D, Park JS, Choi EY, Ahn JA, et al
    Comparison of learning needs priorities between healthcare providers and patients with heart failure.
    PLoS One. 2020;15:e0239656.
    PubMed     Abstract available


  82. HU Z, Du D
    A new analytical framework for missing data imputation and classification with uncertainty: Missing data imputation and heart failure readmission prediction.
    PLoS One. 2020;15:e0237724.
    PubMed     Abstract available


  83. PANDEY M, Xu Z, Sholle E, Maliakal G, et al
    Extraction of radiographic findings from unstructured thoracoabdominal computed tomography reports using convolutional neural network based natural language processing.
    PLoS One. 2020;15:e0236827.
    PubMed     Abstract available


  84. BOBILLO-PEREZ S, Girona-Alarcon M, Corniero P, Sole-Ribalta A, et al
    Pro-atrial natriuretic peptide and pro-adrenomedullin before cardiac surgery in children. Can we predict the future?
    PLoS One. 2020;15:e0236377.
    PubMed     Abstract available


  85. BLAZQUEZ-BERMEJO Z, Farre N, Llagostera M, Caravaca Perez P, et al
    The development of chronic diuretic resistance can be predicted during a heart-failure hospitalization. Results from the REDIHF registry.
    PLoS One. 2020;15:e0240098.
    PubMed     Abstract available


  86. CARABALLO C, McCullough M, Fuery MA, Chouairi F, et al
    COVID-19 infections and outcomes in a live registry of heart failure patients across an integrated health care system.
    PLoS One. 2020;15:e0238829.
    PubMed     Abstract available


  87. LI AH, Palmer KS, Taljaard M, Paterson JM, et al
    Effects of quality-based procedure hospital funding reform in Ontario, Canada: An interrupted time series study.
    PLoS One. 2020;15:e0236480.
    PubMed     Abstract available


  88. STOLINA M, Luo X, Dwyer D, Han CY, et al
    The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15.
    PLoS One. 2020;15:e0231234.
    PubMed     Abstract available


  89. OKANO T, Motoki H, Minamisawa M, Kimura K, et al
    Cardio-renal and cardio-hepatic interactions predict cardiovascular events in elderly patients with heart failure.
    PLoS One. 2020;15:e0241003.
    PubMed     Abstract available


  90. LANGSETH MS, Andersen GO, Husebye T, Arnesen H, et al
    Neutrophil extracellular trap components and myocardial recovery in post-ischemic acute heart failure.
    PLoS One. 2020;15:e0241333.
    PubMed     Abstract available


  91. IACCARINO G, Grassi G, Borghi C, Carugo S, et al
    Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension.
    PLoS One. 2020;15:e0237297.
    PubMed     Abstract available


  92. VALENTE C, Guglielmini C, Domenech O, Contiero B, et al
    Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
    PLoS One. 2020;15:e0238440.
    PubMed     Abstract available


  93. BAVISHI A, Lloyd-Jones DM, Ning H, Vu THT, et al
    Systematic examination of a heart failure risk prediction tool: The pooled cohort equations to prevent heart failure.
    PLoS One. 2020;15:e0240567.
    PubMed     Abstract available


  94. LIU N, Hang T, Gao X, Yang W, et al
    The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis.
    PLoS One. 2020;15:e0238775.
    PubMed     Abstract available


  95. ARMOIRY X, Obadia JF, Auguste P, Connock M, et al
    Conflicting findings between the Mitra-Fr and the Coapt trials: Implications regarding the cost-effectiveness of percutaneous repair for heart failure patients with severe secondary mitral regurgitation.
    PLoS One. 2020;15:e0241361.
    PubMed     Abstract available


  96. SOHN A, Speier W, Lan E, Aoki K, et al
    Integrating remote monitoring into heart failure patients' care regimen: A pilot study.
    PLoS One. 2020;15:e0242210.
    PubMed     Abstract available


  97. MORBACH C, Sahiti F, Tiffe T, Cejka V, et al
    Myocardial work - correlation patterns and reference values from the population-based STAAB cohort study.
    PLoS One. 2020;15:e0239684.
    PubMed     Abstract available


  98. MEZZACAPPA C, Ravindra NG, Caraballo C, Chouairi F, et al
    Clinical implications of differences between real world and clinical trial usage of left ventricular assist devices for end stage heart failure.
    PLoS One. 2020;15:e0242928.
    PubMed     Abstract available


  99. CHECA C, Medina-Perucha L, Munoz MA, Verdu-Rotellar JM, et al
    Living with advanced heart failure: A qualitative study.
    PLoS One. 2020;15:e0243974.
    PubMed     Abstract available


  100. TING SW, Fan PC, Lin YS, Lin MS, et al
    Uremic pruritus and long-term morbidities in the dialysis population.
    PLoS One. 2020;15:e0241088.
    PubMed     Abstract available


  101. HAMMOND MM, Shen C, Li S, Kazi DS, et al
    Retrospective evaluation of echocardiographic variables for prediction of heart failure hospitalization in heart failure with preserved versus reduced ejection fraction: A single center experience.
    PLoS One. 2020;15:e0244379.
    PubMed     Abstract available


  102. KRUIK-KOLLOFFEL WJ, van der Palen J, Doggen CJM, van Maaren MC, et al
    Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases.
    PLoS One. 2020;15:e0244231.
    PubMed     Abstract available


  103. VERHESTRAETEN C, Weijers G, Debleu D, Ciarka A, et al
    Diagnosis, treatment, and follow-up of heart failure patients by general practitioners: A Delphi consensus statement.
    PLoS One. 2020;15:e0244485.
    PubMed     Abstract available


  104. SATO Y, Yoshihisa A, Watanabe K, Hotsuki Y, et al
    Association between platelet distribution width and prognosis in patients with heart failure.
    PLoS One. 2020;15:e0244608.
    PubMed     Abstract available


  105. KATO T, Yaku H, Morimoto T, Inuzuka Y, et al
    Association of an increase in serum albumin levels with positive 1-year outcomes in acute decompensated heart failure: A cohort study.
    PLoS One. 2020;15:e0243818.
    PubMed     Abstract available


  106. DASSANAYAKA S, Brittian KR, Long BW, Higgins LA, et al
    Cardiomyocyte Oga haploinsufficiency increases O-GlcNAcylation but hastens ventricular dysfunction following myocardial infarction.
    PLoS One. 2020;15:e0242250.
    PubMed     Abstract available


  107. HER AY, Choi BG, Rha SW, Kim YH, et al
    The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in patients with acute myocardial infarction without hypertension.
    PLoS One. 2020;15:e0242314.
    PubMed     Abstract available


  108. DE NATTES T, Litzler PY, Gay A, Nafeh-Bizet C, et al
    Hemolysis induced by Left Ventricular Assist Device is associated with proximal tubulopathy.
    PLoS One. 2020;15:e0242931.
    PubMed     Abstract available


  109. SALONEN J, Vahanikkila H, Purokivi M, Kaarteenaho R, et al
    Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases.
    PLoS One. 2020;15:e0242860.
    PubMed     Abstract available


  110. ROH SY, Choi JI, Kim MS, Cho EY, et al
    Incidence and etiology of sudden cardiac arrest in Koreans: A cohort from the national health insurance service database.
    PLoS One. 2020;15:e0242799.
    PubMed     Abstract available


  111. JONES E, Wei J, Nelson MD, Bakir M, et al
    N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
    PLoS One. 2020;15:e0243213.
    PubMed     Abstract available


  112. BARENFELD E, Ali L, Wallstrom S, Fors A, et al
    Becoming more of an insider: A grounded theory study on patients' experience of a person-centred e-health intervention.
    PLoS One. 2020;15:e0241801.
    PubMed     Abstract available


  113. KAZMI SZH, Habib N, Riaz R, Rizvi SS, et al
    Multiscale based nonlinear dynamics analysis of heart rate variability signals.
    PLoS One. 2020;15:e0243441.
    PubMed     Abstract available


    January 2019
  114. WANG ID, Chien WC, Chung CH, Tsai PY, et al
    Non-Apnea Sleep Disorder associates with increased risk of incident heart failure-A nationwide population-based cohort study.
    PLoS One. 2019;14:e0209673.
    PubMed     Abstract available


  115. SILVESTRINI A, Bruno C, Vergani E, Venuti A, et al
    Circulating irisin levels in heart failure with preserved or reduced ejection fraction: A pilot study.
    PLoS One. 2019;14:e0210320.
    PubMed     Abstract available


  116. SEID MA, Abdela OA, Zeleke EG
    Adherence to self-care recommendations and associated factors among adult heart failure patients. From the patients' point of view.
    PLoS One. 2019;14:e0211768.
    PubMed     Abstract available


  117. LEE SJ, Ha KH, Lee JH, Lee H, et al
    Second-line glucose-lowering drugs added to metformin and the risk of hospitalization for heart failure: A nationwide cohort study.
    PLoS One. 2019;14:e0211959.
    PubMed     Abstract available


  118. ZAHID FM, Ramzan S, Faisal S, Hussain I, et al
    Gender based survival prediction models for heart failure patients: A case study in Pakistan.
    PLoS One. 2019;14:e0210602.
    PubMed     Abstract available


  119. TURGEON RD, Kolber MR, Loewen P, Ellis U, et al
    Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis.
    PLoS One. 2019;14:e0212907.
    PubMed     Abstract available


  120. LU Q, Dong N, Wang Q, Yi W, et al
    Correction: Increased Levels of Plasma Soluble Sema4D in Patients with Heart Failure.
    PLoS One. 2019;14:e0214894.
    PubMed     Abstract available


  121. CHEN TY, Kao CW, Cheng SM, Chang YC, et al
    Correction: Uncertainty and depressive symptoms as mediators of quality of life in patients with heart failure.
    PLoS One. 2019;14:e0214825.
    PubMed     Abstract available


  122. SPINAR J, Spinarova L, Malek F, Ludka O, et al
    Prognostic value of NT-proBNP added to clinical parameters to predict two-year prognosis of chronic heart failure patients with mid-range and reduced ejection fraction - A report from FAR NHL prospective registry.
    PLoS One. 2019;14:e0214363.
    PubMed     Abstract available


  123. AMIN A, Garcia Reeves AB, Li X, Dhamane A, et al
    Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure.
    PLoS One. 2019;14:e0213614.
    PubMed     Abstract available


  124. WU MY, Chen TT, Chen YC, Tarng DC, et al
    Correction: Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis.
    PLoS One. 2019;14:e0215624.
    PubMed     Abstract available


  125. LIN TK, You KX, Hsu CT, Li YD, et al
    Negative affectivity and social inhibition are associated with increased cardiac readmission in patients with heart failure: A preliminary observation study.
    PLoS One. 2019;14:e0215726.
    PubMed     Abstract available


  126. GIL-CAYUELA C, Lopez A, Martinez-Dolz L, Gonzalez-Juanatey JR, et al
    The altered expression of autophagy-related genes participates in heart failure: NRBP2 and CALCOCO2 are associated with left ventricular dysfunction parameters in human dilated cardiomyopathy.
    PLoS One. 2019;14:e0215818.
    PubMed     Abstract available


  127. ARGENZIANO MA, Doss MX, Tabler M, Sachinidis A, et al
    Transcriptional changes associated with advancing stages of heart failure underlie atrial and ventricular arrhythmogenesis.
    PLoS One. 2019;14:e0216928.
    PubMed     Abstract available


  128. SHAMALI M, Konradsen H, Stas L, Ostergaard B, et al
    Dyadic effects of perceived social support on family health and family functioning in patients with heart failure and their nearest relatives: Using the Actor-Partner Interdependence Mediation Model.
    PLoS One. 2019;14:e0217970.
    PubMed     Abstract available


  129. HONEYFORD K, Bell D, Chowdhury F, Quint J, et al
    Unscheduled hospital contacts after inpatient discharge: A national observational study of COPD and heart failure patients in England.
    PLoS One. 2019;14:e0218128.
    PubMed     Abstract available


  130. CONTAIFER D JR, Buckley LF, Wohlford G, Kumar NG, et al
    Metabolic modulation predicts heart failure tests performance.
    PLoS One. 2019;14:e0218153.
    PubMed     Abstract available


  131. GRUSTAM AS, Buyukkaramikli N, Koymans R, Vrijhoef HJM, et al
    Value of information analysis in telehealth for chronic heart failure management.
    PLoS One. 2019;14:e0218083.
    PubMed     Abstract available


  132. MILES JA, Quispe R, Mehlman Y, Patel K, et al
    Racial differences and mortality risk in patients with heart failure and hyponatremia.
    PLoS One. 2019;14:e0218504.
    PubMed     Abstract available


  133. MORA MT, Gomez JF, Morley G, Ferrero JM, et al
    Mechanistic investigation of Ca2+ alternans in human heart failure and its modulation by fibroblasts.
    PLoS One. 2019;14:e0217993.
    PubMed     Abstract available


  134. CHEN X, Xin Y, Hu W, Zhao Y, et al
    Quality of life and outcomes in heart failure patients with ejection fractions in different ranges.
    PLoS One. 2019;14:e0218983.
    PubMed     Abstract available


  135. AWAN SE, Bennamoun M, Sohel F, Sanfilippo FM, et al
    Feature selection and transformation by machine learning reduce variable numbers and improve prediction for heart failure readmission or death.
    PLoS One. 2019;14:e0218760.
    PubMed     Abstract available


  136. WANG HW, Ahmad M, Jadayel R, Najjar F, et al
    Inhibition of inflammation by minocycline improves heart failure and depression-like behaviour in rats after myocardial infarction.
    PLoS One. 2019;14:e0217437.
    PubMed     Abstract available


  137. KWON JM, Kim KH, Jeon KH, Lee SE, et al
    Artificial intelligence algorithm for predicting mortality of patients with acute heart failure.
    PLoS One. 2019;14:e0219302.
    PubMed     Abstract available


  138. WANG B, Yang Q, Bai WW, Xing YF, et al
    Correction: Tongxinluo protects against pressure overload-induced heart failure in mice involving VEGF/Akt/eNOS pathway activation.
    PLoS One. 2019;14:e0220845.
    PubMed     Abstract available


  139. RAMALHO SHR, Cipriano Junior G, Vieira PJC, Nakano EY, et al
    Inspiratory muscle strength and six-minute walking distance in heart failure: Prognostic utility in a 10 years follow up cohort study.
    PLoS One. 2019;14:e0220638.
    PubMed     Abstract available


  140. MATSUSHITA K, Sang Y, Yang C, Ballew SH, et al
    Dyskalemia, its patterns, and prognosis among patients with incident heart failure: A nationwide study of US veterans.
    PLoS One. 2019;14:e0219899.
    PubMed     Abstract available


  141. HUANG WM, Sung SH, Yu WC, Cheng HM, et al
    Perturbations of pulsatile hemodynamics and clinical outcomes in patients with acute heart failure and reduced, mid-range or preserved ejection fraction.
    PLoS One. 2019;14:e0220183.
    PubMed     Abstract available


  142. GARCIA-OLMOS L, Aguilar R, Lora D, Carmona M, et al
    Development of a predictive model of hospitalization in primary care patients with heart failure.
    PLoS One. 2019;14:e0221434.
    PubMed     Abstract available


  143. JUNG MH, Kim HL, Choi JH, Lee S, et al
    Heart failure awareness in the Korean general population: Results from the nationwide survey.
    PLoS One. 2019;14:e0222264.
    PubMed     Abstract available


  144. VETROVSKY T, Siranec M, Marencakova J, Tufano JJ, et al
    Validity of six consumer-level activity monitors for measuring steps in patients with chronic heart failure.
    PLoS One. 2019;14:e0222569.
    PubMed     Abstract available


  145. ABEBE TB, Gebreyohannes EA, Tefera YG, Bhagavathula AS, et al
    Correction: The prognosis of heart failure patients: Does sodium level play a significant role?
    PLoS One. 2019;14:e0223007.
    PubMed     Abstract available


  146. GORODESKI EZ, Magnelli-Reyes C, Moennich LA, Grimaldi A, et al
    Cardiac resynchronization therapy-heart failure (CRT-HF) clinic: A novel model of care.
    PLoS One. 2019;14:e0222610.
    PubMed     Abstract available


  147. CHANG TE, Park S, Yang Q, Loustalot F, et al
    Association between long-term adherence to class-I recommended medications and risk for potentially preventable heart failure hospitalizations among younger adults.
    PLoS One. 2019;14:e0222868.
    PubMed     Abstract available


  148. MOON YJ, Kim JW, Bang YS, Lim YS, et al
    Prediction of all-cause mortality after liver transplantation using left ventricular systolic and diastolic function assessment.
    PLoS One. 2019;14:e0209100.
    PubMed     Abstract available


  149. SUN CY, Sung JM, Wang JD, Li CY, et al
    A comparison of the risk of congestive heart failure-related hospitalizations in patients receiving hemodialysis and peritoneal dialysis - A retrospective propensity score-matched study.
    PLoS One. 2019;14:e0223336.
    PubMed     Abstract available


  150. BACKHAUS SJ, Metschies G, Billing M, Kowallick JT, et al
    Cardiovascular magnetic resonance imaging feature tracking: Impact of training on observer performance and reproducibility.
    PLoS One. 2019;14:e0210127.
    PubMed     Abstract available


  151. ABU-HALIMA M, Meese E, Saleh MA, Keller A, et al
    Micro-RNA 150-5p predicts overt heart failure in patients with univentricular hearts.
    PLoS One. 2019;14:e0223606.
    PubMed     Abstract available


  152. ANDERSSON C, Lyass A, Xanthakis V, Larson MG, et al
    Risk factor-based subphenotyping of heart failure in the community.
    PLoS One. 2019;14:e0222886.
    PubMed     Abstract available


  153. LENZI J, Avaldi VM, Molinazzi D, Descovich C, et al
    Are degree of urbanisation and travel times to healthcare services associated with the processes of care and outcomes of heart failure? A retrospective cohort study based on administrative data.
    PLoS One. 2019;14:e0223845.
    PubMed     Abstract available


  154. AXELSEN JB, Andersen S, Sun XQ, Ringgaard S, et al
    Effects of 6-mercaptopurine in pressure overload induced right heart failure.
    PLoS One. 2019;14:e0225122.
    PubMed     Abstract available


  155. HWANG JK, Gwag HB, Park KM, On YK, et al
    Outcomes of cardiac resynchronization therapy in patients with atrial fibrillation accompanied by slow ventricular response.
    PLoS One. 2019;14:e0210603.
    PubMed     Abstract available


  156. FISCHER-RASOKAT U, Renker M, Liebetrau C, Weferling M, et al
    Outcome of patients with heart failure after transcatheter aortic valve implantation.
    PLoS One. 2019;14:e0225473.
    PubMed     Abstract available


  157. GHAZAL F, Theobald H, Rosenqvist M, Al-Khalili F, et al
    Assessment of N-terminal pro-B-type natriuretic peptide level in screening for atrial fibrillation in primary health care.
    PLoS One. 2019;14:e0212974.
    PubMed     Abstract available


  158. DIETL A, Winkel I, Pietrzyk G, Paulus M, et al
    Skeletal muscle alterations in tachycardia-induced heart failure are linked to deficient natriuretic peptide signalling and are attenuated by RAS-/NEP-inhibition.
    PLoS One. 2019;14:e0225937.
    PubMed     Abstract available


  159. KAUFMANN D, Szwoch M, Kwiatkowska J, Raczak G, et al
    Global longitudinal strain can predict heart failure exacerbation in stable outpatients with ischemic left ventricular systolic dysfunction.
    PLoS One. 2019;14:e0225829.
    PubMed     Abstract available


  160. WESTHOFEN S, Jelinek M, Dreher L, Biermann D, et al
    The heterotopic heart transplantation in mice as a small animal model to study mechanical unloading - Establishment of the procedure, perioperative management and postoperative scoring.
    PLoS One. 2019;14:e0214513.
    PubMed     Abstract available


  161. POWER AS, Norman R, Jones TLM, Hickey AJ, et al
    Mitochondrial function remains impaired in the hypertrophied right ventricle of pulmonary hypertensive rats following short duration metoprolol treatment.
    PLoS One. 2019;14:e0214740.
    PubMed     Abstract available


  162. MAO CT, Chen TH, Tseng CN, Chen SW, et al
    Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock.
    PLoS One. 2019;14:e0214417.
    PubMed     Abstract available


  163. VAN DEN HOOGEN P, de Jager SCA, Mol EA, Schoneveld AS, et al
    Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure.
    PLoS One. 2019;14:e0227283.
    PubMed     Abstract available


  164. SORIMACHI H, Kurosawa K, Yoshida K, Obokata M, et al
    Sex differences in left ventricular afterload and diastolic function are independent from the aortic size.
    PLoS One. 2019;14:e0214907.
    PubMed     Abstract available


  165. DECKX S, Johnson DM, Rienks M, Carai P, et al
    Extracellular SPARC increases cardiomyocyte contraction during health and disease.
    PLoS One. 2019;14:e0209534.
    PubMed     Abstract available


  166. HUANG TL, Hsiao FY, Chiang CK, Shen LJ, et al
    Risk of cardiovascular events associated with dipeptidyl peptidase-4 inhibitors in patients with diabetes with and without chronic kidney disease: A nationwide cohort study.
    PLoS One. 2019;14:e0215248.
    PubMed     Abstract available


  167. BRAT K, Stastna N, Merta Z, Olson LJ, et al
    Cardiopulmonary exercise testing for identification of patients with hyperventilation syndrome.
    PLoS One. 2019;14:e0215997.
    PubMed     Abstract available


  168. MCCOY IE, Chertow GM, Chang TI
    Patterns of diuretic use in the intensive care unit.
    PLoS One. 2019;14:e0217911.
    PubMed     Abstract available


  169. EGAN BM, Sutherland SE, Tilkemeier PL, Davis RA, et al
    A cluster-based approach for integrating clinical management of Medicare beneficiaries with multiple chronic conditions.
    PLoS One. 2019;14:e0217696.
    PubMed     Abstract available


  170. REED ME, Huang J, Brand RJ, Neugebauer R, et al
    Patients with complex chronic conditions: Health care use and clinical events associated with access to a patient portal.
    PLoS One. 2019;14:e0217636.
    PubMed     Abstract available


  171. XUE Y, Xu B, Su C, Han Q, et al
    Cardiorenal syndrome in incident peritoneal dialysis patients: What is its effect on patients' outcomes?
    PLoS One. 2019;14:e0218082.
    PubMed     Abstract available


  172. PARK J, Lee J, Kwon A, Choi HJ, et al
    The 2016 ASE/EACVI recommendations may be able to more accurately identify patients at risk for diastolic dysfunction in living donor liver transplantation.
    PLoS One. 2019;14:e0215603.
    PubMed     Abstract available


  173. COZZOLINO F, Montedori A, Abraha I, Eusebi P, et al
    A diagnostic accuracy study validating cardiovascular ICD-9-CM codes in healthcare administrative databases. The Umbria Data-Value Project.
    PLoS One. 2019;14:e0218919.
    PubMed     Abstract available


  174. HAN J, Kubala M, Aranda-Michel E, Trumble DR, et al
    Ventricle-specific epicardial pressures as a means to optimize direct cardiac compression for circulatory support: A pilot study.
    PLoS One. 2019;14:e0219162.
    PubMed     Abstract available


  175. BATLLE M, Castillo N, Alcarraz A, Sarvari S, et al
    Axl expression is increased in early stages of left ventricular remodeling in an animal model with pressure-overload.
    PLoS One. 2019;14:e0217926.
    PubMed     Abstract available


  176. SANTOS JUNIOR OR, da Costa Rocha MO, Rodrigues de Almeida F, Sales da Cunha PF, et al
    Speckle tracking echocardiographic deformation indices in Chagas and idiopathic dilated cardiomyopathy: Incremental prognostic value of longitudinal strain.
    PLoS One. 2019;14:e0221028.
    PubMed     Abstract available


  177. DELGADO GE, Zirlik A, Gruber R, Scheffold T, et al
    The association of high-normal international-normalized-ratio (INR) with mortality in patients referred for coronary angiography.
    PLoS One. 2019;14:e0221112.
    PubMed     Abstract available


  178. NGUYEN QL, Wang Y, Helbling N, Simon MA, et al
    Alterations in platelet bioenergetics in Group 2 PH-HFpEF patients.
    PLoS One. 2019;14:e0220490.
    PubMed     Abstract available


  179. ROUBICEK T, Stros J, Kucera P, Nedbal P, et al
    Combination of left ventricular reverse remodeling and brain natriuretic peptide level at one year after cardiac resynchronization therapy predicts long-term clinical outcome.
    PLoS One. 2019;14:e0219966.
    PubMed     Abstract available


  180. HEARN J, Ssinabulya I, Schwartz JI, Akiteng AR, et al
    Self-management of non-communicable diseases in low- and middle-income countries: A scoping review.
    PLoS One. 2019;14:e0219141.
    PubMed     Abstract available


  181. PHILIP JL, Xu X, Han M, Akhter SA, et al
    Regulation of cardiac fibroblast-mediated maladaptive ventricular remodeling by beta-arrestins.
    PLoS One. 2019;14:e0219011.
    PubMed     Abstract available


  182. ADELBORG K, Nicolaisen SK, Hasvold P, Palaka E, et al
    Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients - A population-based cohort study.
    PLoS One. 2019;14:e0218739.
    PubMed     Abstract available


  183. ARANDA-MICHEL E, Waldman LK, Trumble DR
    Left ventricular simulation of cardiac compression: Hemodynamics and regional mechanics.
    PLoS One. 2019;14:e0224475.
    PubMed     Abstract available


  184. BOZKURT S
    Mathematical modeling of cardiac function to evaluate clinical cases in adults and children.
    PLoS One. 2019;14:e0224663.
    PubMed     Abstract available


  185. OUD L
    In-hospital cardiopulmonary resuscitation of patients with cirrhosis: A population-based analysis.
    PLoS One. 2019;14:e0222873.
    PubMed     Abstract available


  186. TAKEJI Y, Taniguchi T, Morimoto T, Saito N, et al
    Transcatheter aortic valve implantation versus conservative management for severe aortic stenosis in real clinical practice.
    PLoS One. 2019;14:e0222979.
    PubMed     Abstract available


  187. BLANC AL, Fumeaux T, Stirnemann J, Dupuis Lozeron E, et al
    Development of a predictive score for potentially avoidable hospital readmissions for general internal medicine patients.
    PLoS One. 2019;14:e0219348.
    PubMed     Abstract available


  188. NACHAR W, Merlet N, Maafi F, Shi Y, et al
    Cardiac inflammation and diastolic dysfunction in hypercholesterolemic rabbits.
    PLoS One. 2019;14:e0220707.
    PubMed     Abstract available


  189. MONTENEGRO CAMANHO LE, Benchimol Saad E, Slater C, Oliveira Inacio Junior LA, et al
    Clinical outcomes and mortality in old and very old patients undergoing cardiac resynchronization therapy.
    PLoS One. 2019;14:e0225612.
    PubMed     Abstract available


  190. AHMED MM, Roukoz H, Trivedi JR, Bhan A, et al
    Questionable utility of digoxin in left-ventricular assist device recipients: A multicenter, retrospective analysis.
    PLoS One. 2019;14:e0225628.
    PubMed     Abstract available


  191. INGRASCIOTTA Y, Sultana J, Giorgianni F, Menditto E, et al
    Analgesic drug use in elderly persons: A population-based study in Southern Italy.
    PLoS One. 2019;14:e0222836.
    PubMed     Abstract available


  192. STEVENS M, Shenoy AV, Munson SH, Yapici HO, et al
    Healthcare utilization and costs of cardiopulmonary complications following cardiac surgery in the United States.
    PLoS One. 2019;14:e0226750.
    PubMed     Abstract available


  193. BERENT TE, Dorschner JM, Meyer T, Craig TA, et al
    Impaired cardiac performance, protein synthesis, and mitochondrial function in tumor-bearing mice.
    PLoS One. 2019;14:e0226440.
    PubMed     Abstract available


  194. OTA Y, Kitamura M, Muta K, Yamashita H, et al
    Effect of statin on life prognosis in Japanese patients undergoing hemodialysis.
    PLoS One. 2019;14:e0224111.
    PubMed     Abstract available


  195. GERGS U, Jahn T, Werner F, Kohler C, et al
    Overexpression of protein phosphatase 5 in the mouse heart: Reduced contractility but increased stress tolerance - Two sides of the same coin?
    PLoS One. 2019;14:e0221289.
    PubMed     Abstract available


    January 2018
  196. LEVIN RK, Katz M, Saldiva PHN, Caixeta A, et al
    Increased hospitalizations for decompensated heart failure and acute myocardial infarction during mild winters: A seven-year experience in the public health system of the largest city in Latin America.
    PLoS One. 2018;13:e0190733.
    PubMed     Abstract available


  197. EGGIMANN L, Blum S, Aeschbacher S, Reusser A, et al
    Risk factors for heart failure hospitalizations among patients with atrial fibrillation.
    PLoS One. 2018;13:e0191736.
    PubMed     Abstract available


  198. MARTIN B, Gabris-Weber BA, Reddy R, Romero G, et al
    Relaxin reverses inflammatory and immune signals in aged hearts.
    PLoS One. 2018;13:e0190935.
    PubMed     Abstract available


  199. AMAR A, Zlochiver S, Barnea O
    Mechano-electric feedback effects in a three-dimensional (3D) model of the contracting cardiac ventricle.
    PLoS One. 2018;13:e0191238.
    PubMed     Abstract available


  200. PUJADES-RODRIGUEZ M, Guttmann OP, Gonzalez-Izquierdo A, Duyx B, et al
    Identifying unmet clinical need in hypertrophic cardiomyopathy using national electronic health records.
    PLoS One. 2018;13:e0191214.
    PubMed     Abstract available


  201. VALLABHAJOSYULA S, Sakhuja A, Geske JB, Kumar M, et al
    Clinical profile and outcomes of acute cardiorenal syndrome type-5 in sepsis: An eight-year cohort study.
    PLoS One. 2018;13:e0190965.
    PubMed     Abstract available


  202. KITAGAWA T, Oda N, Mizukawa M, Hidaka T, et al
    Hospitalization and medical cost of patients with elevated serum N-terminal pro-brain natriuretic peptide levels.
    PLoS One. 2018;13:e0190979.
    PubMed     Abstract available


  203. MLAKAR M, Puddu PE, Somrak M, Bonfiglio S, et al
    Mining telemonitored physiological data and patient-reported outcomes of congestive heart failure patients.
    PLoS One. 2018;13:e0190323.
    PubMed     Abstract available


  204. BECHER PM, Hinrichs S, Fluschnik N, Hennigs JK, et al
    Role of Toll-like receptors and interferon regulatory factors in different experimental heart failure models of diverse etiology: IRF7 as novel cardiovascular stress-inducible factor.
    PLoS One. 2018;13:e0193844.
    PubMed     Abstract available


  205. GOTSMAN I, Shauer A, Elizur Y, Zwas DR, et al
    Temporal changes in electrocardiographic frontal QRS-T angle and survival in patients with heart failure.
    PLoS One. 2018;13:e0194520.
    PubMed     Abstract available


  206. BASSAND JP, Accetta G, Al Mahmeed W, Corbalan R, et al
    Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation.
    PLoS One. 2018;13:e0191592.
    PubMed     Abstract available


  207. NIRSCHL JJ, Janowczyk A, Peyster EG, Frank R, et al
    A deep-learning classifier identifies patients with clinical heart failure using whole-slide images of H&E tissue.
    PLoS One. 2018;13:e0192726.
    PubMed     Abstract available


  208. PAN G, Munukutla S, Kar A, Gardinier J, et al
    Type-2 diabetic aldehyde dehydrogenase 2 mutant mice (ALDH 2*2) exhibiting heart failure with preserved ejection fraction phenotype can be determined by exercise stress echocardiography.
    PLoS One. 2018;13:e0195796.
    PubMed     Abstract available


  209. CHEN YJ, Wang JS, Hsu CC, Lin PJ, et al
    Cerebral desaturation in heart failure: Potential prognostic value and physiologic basis.
    PLoS One. 2018;13:e0196299.
    PubMed     Abstract available


  210. UMINSKI K, Komenda P, Whitlock R, Ferguson T, et al
    Effect of post-discharge virtual wards on improving outcomes in heart failure and non-heart failure populations: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0196114.
    PubMed     Abstract available


  211. AWAN I, Aziz W, Shah IH, Habib N, et al
    Studying the dynamics of interbeat interval time series of healthy and congestive heart failure subjects using scale based symbolic entropy analysis.
    PLoS One. 2018;13:e0196823.
    PubMed     Abstract available


  212. FLUSCHNIK N, Ojeda F, Zeller T, Jorgensen T, et al
    Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease.
    PLoS One. 2018;13:e0197497.
    PubMed     Abstract available


  213. OKUHARA Y, Asakura M, Azuma K, Orihara Y, et al
    Effects of early diuretic response to carperitide in acute decompensated heart failure treatment: A single-center retrospective study.
    PLoS One. 2018;13:e0199263.
    PubMed     Abstract available


  214. NAYYAR S, Suszko A, Porta-Sanchez A, Dalvi R, et al
    Reduced T wave alternans in heart failure responders to cardiac resynchronization therapy: Evidence of electrical remodeling.
    PLoS One. 2018;13:e0199637.
    PubMed     Abstract available


  215. CAVALCANTE DFB, Brizon VSC, Probst LF, Meneghim MC, et al
    Did the Family Health Strategy have an impact on indicators of hospitalizations for stroke and heart failure? Longitudinal study in Brazil: 1998-2013.
    PLoS One. 2018;13:e0198428.
    PubMed     Abstract available


  216. MA QQ, Fan XD, Li T, Hao YY, et al
    Short- and long-term prognostic value of hyponatremia in patients with acute coronary syndrome: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0193857.
    PubMed     Abstract available


  217. DI CARLO A, Lamassa M, Franceschini M, Bovis F, et al
    Impact of acute-phase complications and interventions on 6-month survival after stroke. A prospective observational study.
    PLoS One. 2018;13:e0194786.
    PubMed     Abstract available


  218. SETHI NJ, Nielsen EE, Safi S, Feinberg J, et al
    Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    PLoS One. 2018;13:e0193924.
    PubMed     Abstract available


  219. LIN J, Qin Z, Qian H, Li Y, et al
    A novel catheter with retractable stent that can prevent aortic insufficiency during left ventricular assist.
    PLoS One. 2018;13:e0194658.
    PubMed     Abstract available


  220. HAN BG, Song SH, Yoo JS, Park H, et al
    Association between OH/ECW and echocardiographic parameters in CKD5 patients not undergoing dialysis.
    PLoS One. 2018;13:e0195202.
    PubMed     Abstract available


  221. XIAO C, Ma T, Dieng AB, Blei DM, et al
    Readmission prediction via deep contextual embedding of clinical concepts.
    PLoS One. 2018;13:e0195024.
    PubMed     Abstract available


  222. BARBIERI F, Dichtl W, Heidbreder A, Brandauer E, et al
    Sleep apnea detection by a cardiac resynchronization device integrated thoracic impedance sensor: A validation study against the gold standard polysomnography.
    PLoS One. 2018;13:e0195573.
    PubMed     Abstract available


  223. DALGAARD F, Ruwald MH, Lindhardt TB, Gislason GH, et al
    Patients with atrial fibrillation and permanent pacemaker: Temporal changes in patient characteristics and pharmacotherapy.
    PLoS One. 2018;13:e0195175.
    PubMed     Abstract available


  224. PARK J, Kim J, Kwon JH, Park SJ, et al
    Association between perioperative beta-blocker use and clinical outcome of non-cardiac surgery in coronary revascularized patients without severe ventricular dysfunction or heart failure.
    PLoS One. 2018;13:e0201311.
    PubMed     Abstract available


  225. CLEMENTY N, Garcia B, Andre C, Bisson A, et al
    Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure.
    PLoS One. 2018;13:e0201517.
    PubMed     Abstract available


  226. YE L, Su L, Wang C, Loo S, et al
    Truncations of the titin Z-disc predispose to a heart failure with preserved ejection phenotype in the context of pressure overload.
    PLoS One. 2018;13:e0201498.
    PubMed     Abstract available


  227. KOHLI P, Staziaki PV, Janjua SA, Addison DA, et al
    The effect of emphysema on readmission and survival among smokers with heart failure.
    PLoS One. 2018;13:e0201376.
    PubMed     Abstract available


  228. ANDENAES K, Lunde IG, Mohammadzadeh N, Dahl CP, et al
    The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling.
    PLoS One. 2018;13:e0201422.
    PubMed     Abstract available


  229. LOKHANDWALA S, McCague N, Chahin A, Escobar B, et al
    One-year mortality after recovery from critical illness: A retrospective cohort study.
    PLoS One. 2018;13:e0197226.
    PubMed     Abstract available


  230. CHEN KH, Chen YT, Yeh SL, Weng LC, et al
    Changes in quality of life and health status in patients with extracorporeal life support: A prospective longitudinal study.
    PLoS One. 2018;13:e0196778.
    PubMed     Abstract available


  231. MESSNER M, Ghadge SK, Goetsch V, Wimmer A, et al
    Upregulation of the aging related LMNA splice variant progerin in dilated cardiomyopathy.
    PLoS One. 2018;13:e0196739.
    PubMed     Abstract available


  232. WEERAHANDI H, Ziaeian B, Fogerty RL, Jenq GY, et al
    Predictors for patients understanding reason for hospitalization.
    PLoS One. 2018;13:e0196479.
    PubMed     Abstract available


  233. HARA T, Nishimura S, Yamamoto T, Kajimoto Y, et al
    TAK-272 (imarikiren), a novel renin inhibitor, improves cardiac remodeling and mortality in a murine heart failure model.
    PLoS One. 2018;13:e0202176.
    PubMed     Abstract available


  234. VAN DEN BERGE JC, Constantinescu AA, van Domburg RT, Brankovic M, et al
    Renal function and anemia in relation to short- and long-term prognosis of patients with acute heart failure in the period 1985-2008: A clinical cohort study.
    PLoS One. 2018;13:e0201714.
    PubMed     Abstract available


  235. BOIVIN-JAHNS V, Uhland K, Holthoff HP, Beyersdorf N, et al
    Cyclopeptide COR-1 to treat beta1-adrenergic receptor antibody-induced heart failure.
    PLoS One. 2018;13:e0201160.
    PubMed     Abstract available


  236. DUBROCK HM, AbouEzzeddine OF, Redfield MM
    High-sensitivity C-reactive protein in heart failure with preserved ejection fraction.
    PLoS One. 2018;13:e0201836.
    PubMed     Abstract available


  237. FORS A, Blanck E, Ali L, Ekberg-Jansson A, et al
    Effects of a person-centred telephone-support in patients with chronic obstructive pulmonary disease and/or chronic heart failure - A randomized controlled trial.
    PLoS One. 2018;13:e0203031.
    PubMed     Abstract available


  238. PAN G, Munukutla S, Kar A, Gardinier J, et al
    Correction: Type-2 diabetic aldehyde dehydrogenase 2 mutant mice (ALDH 2*2) exhibiting heart failure with preserved ejection fraction phenotype can be determined by exercise stress echocardiography.
    PLoS One. 2018;13:e0203581.
    PubMed     Abstract available


  239. STRAUSS E, Tomczak J, Staniszewski R, Oszkinis G, et al
    Associations and interactions between variants in selenoprotein genes, selenoprotein levels and the development of abdominal aortic aneurysm, peripheral arterial disease, and heart failure.
    PLoS One. 2018;13:e0203350.
    PubMed     Abstract available


  240. ELCHINOVA E, Teubel I, Roura S, Fernandez MA, et al
    Circulating monocyte subsets and heart failure prognosis.
    PLoS One. 2018;13:e0204074.
    PubMed     Abstract available


  241. VANNINEN SUM, Leivo K, Seppala EH, Aalto-Setala K, et al
    Heterozygous junctophilin-2 (JPH2) p.(Thr161Lys) is a monogenic cause for HCM with heart failure.
    PLoS One. 2018;13:e0203422.
    PubMed     Abstract available


  242. WU WT, Chu CY, Hsu PC, Lee WH, et al
    Impact of the duration of the evidence-based medicine use in acute heart failure: A nationwide cohort study.
    PLoS One. 2018;13:e0205440.
    PubMed     Abstract available


  243. GUAY CA, Morin-Thibault LV, Bonnet S, Lacasse Y, et al
    Pulmonary hypertension-targeted therapies in heart failure: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0204610.
    PubMed     Abstract available


  244. LIU L, Zhao W, Liu J, Gan Y, et al
    Epigallocatechin-3 gallate prevents pressure overload-induced heart failure by up-regulating SERCA2a via histone acetylation modification in mice.
    PLoS One. 2018;13:e0205123.
    PubMed     Abstract available


  245. LAKHANI HV, Khanal T, Gabi A, Yousef G, et al
    Developing a panel of biomarkers and miRNA in patients with myocardial infarction for early intervention strategies of heart failure in West Virginian population.
    PLoS One. 2018;13:e0205329.
    PubMed     Abstract available


  246. NIRIAYO YL, Kumela K, Kassa TD, Angamo MT, et al
    Drug therapy problems and contributing factors in the management of heart failure patients in Jimma University Specialized Hospital, Southwest Ethiopia.
    PLoS One. 2018;13:e0206120.
    PubMed     Abstract available


  247. PEARSON MJ, Smart NA
    Reported methods for handling missing change standard deviations in meta-analyses of exercise therapy interventions in patients with heart failure: A systematic review.
    PLoS One. 2018;13:e0205952.
    PubMed     Abstract available


  248. ABEBE TB, Gebreyohannes EA, Tefera YG, Bhagavathula AS, et al
    The prognosis of heart failure patients: Does sodium level play a significant role?
    PLoS One. 2018;13:e0207242.
    PubMed     Abstract available


  249. TAKIMURA H, Hada T, Kawano M, Yabe T, et al
    A novel validated method for predicting the risk of re-hospitalization for worsening heart failure and the effectiveness of the diuretic upgrading therapy with tolvaptan.
    PLoS One. 2018;13:e0207481.
    PubMed     Abstract available


  250. AU-YEUNG WM, Reinhall PG, Bardy GH, Brunton SL, et al
    Development and validation of warning system of ventricular tachyarrhythmia in patients with heart failure with heart rate variability data.
    PLoS One. 2018;13:e0207215.
    PubMed     Abstract available


  251. CHEN TY, Kao CW, Cheng SM, Chang YC, et al
    Uncertainty and depressive symptoms as mediators of quality of life in patients with heart failure.
    PLoS One. 2018;13:e0205953.
    PubMed     Abstract available


  252. PAVO N, Yarragudi R, Puttinger H, Arfsten H, et al
    Parameters associated with therapeutic response using peritoneal dialysis for therapy refractory heart failure and congestive right ventricular dysfunction.
    PLoS One. 2018;13:e0206830.
    PubMed     Abstract available


  253. KHANAM SS, Choi E, Son JW, Lee JW, et al
    Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.
    PLoS One. 2018;13:e0206380.
    PubMed     Abstract available


  254. MEZZANI A, Pistono M, Agostoni P, Giordano A, et al
    Exercise gas exchange in continuous-flow left ventricular assist device recipients.
    PLoS One. 2018;13:e0187112.
    PubMed     Abstract available


  255. CHO JY, Kim KH, Cho HJ, Lee HY, et al
    Nutritional risk index as a predictor of mortality in acutely decompensated heart failure.
    PLoS One. 2018;13:e0209088.
    PubMed     Abstract available


  256. COPS J, Mullens W, Verbrugge FH, Swennen Q, et al
    Selective abdominal venous congestion to investigate cardiorenal interactions in a rat model.
    PLoS One. 2018;13:e0197687.
    PubMed     Abstract available


  257. DUBIN RF, Whooley M, Pico A, Ganz P, et al
    Proteomic analysis of heart failure hospitalization among patients with chronic kidney disease: The Heart and Soul Study.
    PLoS One. 2018;13:e0208042.
    PubMed     Abstract available


  258. CHO H, Oh SH, Lee H, Cho HJ, et al
    The incremental economic burden of heart failure: A population-based investigation from South Korea.
    PLoS One. 2018;13:e0208731.
    PubMed     Abstract available


  259. CARAVITA S, Faini A, Carolino D'Araujo S, Dewachter C, et al
    Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
    PLoS One. 2018;13:e0199164.
    PubMed     Abstract available


  260. BLAIN AM, Greally E, McClorey G, Manzano R, et al
    Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy.
    PLoS One. 2018;13:e0198897.
    PubMed     Abstract available


  261. BOKSLAG A, Franssen C, Alma LJ, Kovacevic I, et al
    Early-onset preeclampsia predisposes to preclinical diastolic left ventricular dysfunction in the fifth decade of life: An observational study.
    PLoS One. 2018;13:e0198908.
    PubMed     Abstract available


  262. KARUPPAGOUNDER V, Bajpai A, Meng S, Arumugam S, et al
    Small molecule disruption of G protein betagamma subunit signaling reprograms human macrophage phenotype and prevents autoimmune myocarditis in rats.
    PLoS One. 2018;13:e0200697.
    PubMed     Abstract available


  263. RAMCHAND J, Patel SK, Srivastava PM, Farouque O, et al
    Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease.
    PLoS One. 2018;13:e0198144.
    PubMed     Abstract available


  264. SANDSTEDT M, Rotter Sopasakis V, Lundqvist A, Vukusic K, et al
    Hypoxic cardiac fibroblasts from failing human hearts decrease cardiomyocyte beating frequency in an ALOX15 dependent manner.
    PLoS One. 2018;13:e0202693.
    PubMed     Abstract available


  265. DAHROUGE S, Kaczorowski J, Dolovich L, Paterson M, et al
    Long term outcomes of cluster randomized trial to improve cardiovascular health at population level: The Cardiovascular Health Awareness Program (CHAP).
    PLoS One. 2018;13:e0201802.
    PubMed     Abstract available


  266. SANDGREN E, Rorsman C, Edvardsson N, Engdahl J, et al
    Stroke incidence and anticoagulation treatment in patients with pacemaker-detected silent atrial fibrillation.
    PLoS One. 2018;13:e0203661.
    PubMed     Abstract available


  267. LASTRUCCI V, D'Arienzo S, Collini F, Lorini C, et al
    Diagnosis-related differences in the quality of end-of-life care: A comparison between cancer and non-cancer patients.
    PLoS One. 2018;13:e0204458.
    PubMed     Abstract available


  268. OYENUGA AO, Couper D, Matsushita K, Boerwinkle E, et al
    Association of monocyte myeloperoxidase with incident cardiovascular disease: The Atherosclerosis Risk in Communities Study.
    PLoS One. 2018;13:e0205310.
    PubMed     Abstract available


  269. RYSINSKA A, Skoldenberg O, Garland A, Rolfson O, et al
    Aseptic loosening after total hip arthroplasty and the risk of cardiovascular disease: A nested case-control study.
    PLoS One. 2018;13:e0204391.
    PubMed     Abstract available


  270. SCHUMACHER K, Buttner P, Dagres N, Sommer P, et al
    Association between PR interval prolongation and electro-anatomical substrate in patients with atrial fibrillation.
    PLoS One. 2018;13:e0206933.
    PubMed     Abstract available


  271. ZOPPINI G, Bergamini C, Mantovani A, Dauriz M, et al
    The E/e' ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies.
    PLoS One. 2018;13:e0209794.
    PubMed     Abstract available


    January 2017
  272. GROIS L, Hupf J, Reinders J, Schroder J, et al
    Combined Inhibition of the Renin-Angiotensin System and Neprilysin Positively Influences Complex Mitochondrial Adaptations in Progressive Experimental Heart Failure.
    PLoS One. 2017;12:e0169743.
    PubMed     Abstract available


  273. PELLO LAZARO AM, Cristobal C, Franco-Pelaez JA, Tarin N, et al
    Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease.
    PLoS One. 2017;12:e0169826.
    PubMed     Abstract available


  274. ARCOPINTO M, Salzano A, Giallauria F, Bossone E, et al
    Growth Hormone Deficiency Is Associated with Worse Cardiac Function, Physical Performance, and Outcome in Chronic Heart Failure: Insights from the T.O.S.CA. GHD Study.
    PLoS One. 2017;12:e0170058.
    PubMed     Abstract available


  275. TUNG YC, Chang GM, Chang HY, Yu TH, et al
    Relationship between Early Physician Follow-Up and 30-Day Readmission after Acute Myocardial Infarction and Heart Failure.
    PLoS One. 2017;12:e0170061.
    PubMed     Abstract available


  276. PATEL B, Ismahil MA, Hamid T, Bansal SS, et al
    Mononuclear Phagocytes Are Dispensable for Cardiac Remodeling in Established Pressure-Overload Heart Failure.
    PLoS One. 2017;12:e0170781.
    PubMed     Abstract available


  277. AL-GOBARI M, Le HH, Fall M, Gueyffier F, et al
    No benefits of statins for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: A meta-analysis of randomized controlled trials.
    PLoS One. 2017;12:e0171168.
    PubMed     Abstract available


  278. MASCHERBAUER J, Kammerlander AA, Zotter-Tufaro C, Aschauer S, et al
    Presence of isolated tricuspid regurgitation should prompt the suspicion of heart failure with preserved ejection fraction.
    PLoS One. 2017;12:e0171542.
    PubMed     Abstract available


  279. FARRE N, Vela E, Cleries M, Bustins M, et al
    Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients.
    PLoS One. 2017;12:e0172745.
    PubMed     Abstract available


  280. VALBUSA F, Bonapace S, Agnoletti D, Scala L, et al
    Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure.
    PLoS One. 2017;12:e0173398.
    PubMed     Abstract available


  281. NAGA PRASAD SV, Gupta MK, Duan ZH, Surampudi VS, et al
    A unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks.
    PLoS One. 2017;12:e0170456.
    PubMed     Abstract available


  282. KAMO T, Akazawa H, Suda W, Saga-Kamo A, et al
    Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure.
    PLoS One. 2017;12:e0174099.
    PubMed     Abstract available


  283. GLEESON S, Liao YW, Dugo C, Cave A, et al
    ECG-derived spatial QRS-T angle is associated with ICD implantation, mortality and heart failure admissions in patients with LV systolic dysfunction.
    PLoS One. 2017;12:e0171069.
    PubMed     Abstract available


  284. RIBA A, Deres L, Eros K, Szabo A, et al
    Doxycycline protects against ROS-induced mitochondrial fragmentation and ISO-induced heart failure.
    PLoS One. 2017;12:e0175195.
    PubMed     Abstract available


  285. TAKASHIO S, Nagai T, Sugano Y, Honda S, et al
    Persistent increase in cardiac troponin T at hospital discharge predicts repeat hospitalization in patients with acute decompensated heart failure.
    PLoS One. 2017;12:e0173336.
    PubMed     Abstract available


  286. IVANOV A, Mohamed A, Asfour A, Ho J, et al
    Right atrial volume by cardiovascular magnetic resonance predicts mortality in patients with heart failure with reduced ejection fraction.
    PLoS One. 2017;12:e0173245.
    PubMed     Abstract available



  287. Correction: Right atrial volume by cardiovascular magnetic resonance predicts mortality in patients with heart failure with reduced ejection fraction.
    PLoS One. 2017;12:e0176942.
    PubMed     Abstract available


  288. YIN FH, Fan CL, Guo YY, Zhu H, et al
    The impact of gender difference on clinical and echocardiographic outcomes in patients with heart failure after cardiac resynchronization therapy: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0176248.
    PubMed     Abstract available


  289. ICHIKAWA Y, Zemljic-Harpf AE, Zhang Z, McKirnan MD, et al
    Modulation of caveolins, integrins and plasma membrane repair proteins in anthracycline-induced heart failure in rabbits.
    PLoS One. 2017;12:e0177660.
    PubMed     Abstract available


  290. VEGTER EL, Ovchinnikova ES, Sillje HHW, Meems LMG, et al
    Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure.
    PLoS One. 2017;12:e0177242.
    PubMed     Abstract available


  291. STRAM AR, Wagner GR, Fogler BD, Pride PM, et al
    Progressive mitochondrial protein lysine acetylation and heart failure in a model of Friedreich's ataxia cardiomyopathy.
    PLoS One. 2017;12:e0178354.
    PubMed     Abstract available


  292. ALBADRI A, Lai K, Wei J, Landes S, et al
    Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    PLoS One. 2017;12:e0177684.
    PubMed     Abstract available


  293. GASPERONI F, Ieva F, Barbati G, Scagnetto A, et al
    Multi-state modelling of heart failure care path: A population-based investigation from Italy.
    PLoS One. 2017;12:e0179176.
    PubMed     Abstract available


  294. BREEDT E, Lacerda L, Essop MF
    Trimetazidine therapy for diabetic mouse hearts subjected to ex vivo acute heart failure.
    PLoS One. 2017;12:e0179509.
    PubMed     Abstract available


  295. HAN Z, Chen Z, Lan R, Di W, et al
    Sex-specific mortality differences in heart failure patients with ischemia receiving cardiac resynchronization therapy.
    PLoS One. 2017;12:e0180513.
    PubMed     Abstract available


  296. NGUYEN UC, Maffessanti F, Mafi-Rad M, Conte G, et al
    Evaluation of the use of unipolar voltage amplitudes for detection of myocardial scar assessed by cardiac magnetic resonance imaging in heart failure patients.
    PLoS One. 2017;12:e0180637.
    PubMed     Abstract available


  297. AHMAD T, Munir A, Bhatti SH, Aftab M, et al
    Survival analysis of heart failure patients: A case study.
    PLoS One. 2017;12:e0181001.
    PubMed     Abstract available


  298. PUNCHIK B, Komarov R, Gavrikov D, Semenov A, et al
    Can home care for homebound patients with chronic heart failure reduce hospitalizations and costs?
    PLoS One. 2017;12:e0182148.
    PubMed     Abstract available


  299. MONTGOMERY MD, Chan T, Swigart PM, Myagmar BE, et al
    An Alpha-1A Adrenergic Receptor Agonist Prevents Acute Doxorubicin Cardiomyopathy in Male Mice.
    PLoS One. 2017;12:e0168409.
    PubMed     Abstract available


  300. MATSUSHITA K, Kwak L, Hyun N, Bessel M, et al
    Community burden and prognostic impact of reduced kidney function among patients hospitalized with acute decompensated heart failure: The Atherosclerosis Risk in Communities (ARIC) Study Community Surveillance.
    PLoS One. 2017;12:e0181373.
    PubMed     Abstract available


  301. LORIN J, Guilland JC, Stamboul K, Guenancia C, et al
    Increased Symmetric Dimethylarginine Level Is Associated with Worse Hospital Outcomes through Altered Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction.
    PLoS One. 2017;12:e0169979.
    PubMed     Abstract available


  302. ETTINGER G, Burton JP, Gloor GB, Reid G, et al
    Lactobacillus rhamnosus GR-1 Attenuates Induction of Hypertrophy in Cardiomyocytes but Not through Secreted Protein MSP-1 (p75).
    PLoS One. 2017;12:e0168622.
    PubMed     Abstract available


  303. FELDMANN C, Zayat R, Goetzenich A, Aljalloud A, et al
    Perioperative onset of acquired von Willebrand syndrome: Comparison between HVAD, HeartMate II and on-pump coronary bypass surgery.
    PLoS One. 2017;12:e0171029.
    PubMed     Abstract available


  304. WERNLY B, Lichtenauer M, Franz M, Kabisch B, et al
    Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance.
    PLoS One. 2017;12:e0170987.
    PubMed     Abstract available


  305. KUSAKARI Y, Urashima T, Shimura D, Amemiya E, et al
    Impairment of Excitation-Contraction Coupling in Right Ventricular Hypertrophied Muscle with Fibrosis Induced by Pulmonary Artery Banding.
    PLoS One. 2017;12:e0169564.
    PubMed     Abstract available


  306. YANG X, Liu L, Hao Q, Zou D, et al
    Development and Evaluation of Up-Converting Phosphor Technology-Based Lateral Flow Assay for Quantitative Detection of NT-proBNP in Blood.
    PLoS One. 2017;12:e0171376.
    PubMed     Abstract available


  307. WEI W, Liao H, Xue Y, Fang X, et al
    Long-Term Outcomes of Radio-Frequency Catheter Ablation on Ventricular Tachycardias Due to Arrhythmogenic Right Ventricular Cardiomyopathy: A Single Center Experience.
    PLoS One. 2017;12:e0169863.
    PubMed     Abstract available


  308. RAMACHANDRAN S, Lowenthal A, Ritner C, Lowenthal S, et al
    Plasma microvesicle analysis identifies microRNA 129-5p as a biomarker of heart failure in univentricular heart disease.
    PLoS One. 2017;12:e0183624.
    PubMed     Abstract available


  309. GANGA HV, Leung A, Jantz J, Choudhary G, et al
    Supervised exercise training versus usual care in ambulatory patients with left ventricular assist devices: A systematic review.
    PLoS One. 2017;12:e0174323.
    PubMed     Abstract available


  310. KREUSSER MM, Lehmann LH, Haass M, Buss SJ, et al
    Depletion of cardiac catecholamine stores impairs cardiac norepinephrine re-uptake by downregulation of the norepinephrine transporter.
    PLoS One. 2017;12:e0172070.
    PubMed     Abstract available


  311. MCDERMOTT-ROE C, Leleu M, Rowe GC, Palygin O, et al
    Transcriptome-wide co-expression analysis identifies LRRC2 as a novel mediator of mitochondrial and cardiac function.
    PLoS One. 2017;12:e0170458.
    PubMed     Abstract available


  312. KIM J, Hwang J, Choi JH, Choi HI, et al
    Frequency and clinical impact of retained implantable cardioverter defibrillator lead materials in heart transplant recipients.
    PLoS One. 2017;12:e0176925.
    PubMed     Abstract available


  313. WONG CS, Lin YC, Sung LC, Chen TT, et al
    Increased long-term risk of major adverse cardiovascular events in patients with carbon monoxide poisoning: A population-based study in Taiwan.
    PLoS One. 2017;12:e0176465.
    PubMed     Abstract available


  314. WU MY, Chen TT, Chen YC, Tarng DC, et al
    Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis.
    PLoS One. 2017;12:e0184380.
    PubMed     Abstract available


  315. WANG B, Xu M, Li W, Li X, et al
    Aerobic exercise protects against pressure overload-induced cardiac dysfunction and hypertrophy via beta3-AR-nNOS-NO activation.
    PLoS One. 2017;12:e0179648.
    PubMed     Abstract available


  316. GRANDNER MA, Winkelman JW
    Nocturnal leg cramps: Prevalence and associations with demographics, sleep disturbance symptoms, medical conditions, and cardiometabolic risk factors.
    PLoS One. 2017;12:e0178465.
    PubMed     Abstract available


  317. SHAQURA M, Mohamed DM, Aboryag NB, Bedewi L, et al
    Pathological alterations in liver injury following congestive heart failure induced by volume overload in rats.
    PLoS One. 2017;12:e0184161.
    PubMed     Abstract available


  318. FRESIELLO L, Rademakers F, Claus P, Ferrari G, et al
    Exercise physiology with a left ventricular assist device: Analysis of heart-pump interaction with a computational simulator.
    PLoS One. 2017;12:e0181879.
    PubMed     Abstract available


  319. ALGHAMDI M, Al-Mallah M, Keteyian S, Brawner C, et al
    Predicting diabetes mellitus using SMOTE and ensemble machine learning approach: The Henry Ford ExercIse Testing (FIT) project.
    PLoS One. 2017;12:e0179805.
    PubMed     Abstract available


  320. SON MK, Lim NK, Kim HW, Park HY, et al
    Risk of ischemic stroke after atrial fibrillation diagnosis: A national sample cohort.
    PLoS One. 2017;12:e0179687.
    PubMed     Abstract available


  321. LEE MS, Kuo LL, Tan EC, Lee OK, et al
    Is normal-tension glaucoma a risk factor for stroke?-A 10-year follow-up study.
    PLoS One. 2017;12:e0179307.
    PubMed     Abstract available


  322. KOHARA M, Masuda T, Shiizaki K, Akimoto T, et al
    Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease.
    PLoS One. 2017;12:e0178971.
    PubMed     Abstract available


  323. NAMUKWAYA E, Murray SA, Downing J, Leng M, et al
    'I think my body has become addicted to those tablets'. Chronic heart failure patients' understanding of and beliefs about their illness and its treatment: A qualitative longitudinal study from Uganda.
    PLoS One. 2017;12:e0182876.
    PubMed     Abstract available


  324. KEDDIS MT, El-Zoghby Z, Kaplan B, Meeusen JW, et al
    Soluble ST2 does not change cardiovascular risk prediction compared to cardiac troponin T in kidney transplant candidates.
    PLoS One. 2017;12:e0181123.
    PubMed     Abstract available


  325. SHIN MS, An M, Kim S, Shim JL, et al
    Concomitant diastolic dysfunction further interferes with cognitive performance in moderate to severe systolic heart failure.
    PLoS One. 2017;12:e0184981.
    PubMed     Abstract available


  326. RUDEBUSCH J, Benkner A, Poesch A, Dorr M, et al
    Dynamic adaptation of myocardial proteome during heart failure development.
    PLoS One. 2017;12:e0185915.
    PubMed     Abstract available


  327. RACCA V, Castiglioni P, Panzarino C, Oliva F, et al
    End-stage heart failure: Two surgical approaches with different rehabilitative outcomes.
    PLoS One. 2017;12:e0185717.
    PubMed     Abstract available


  328. RAMIREZ J, Orini M, Minchole A, Monasterio V, et al
    Sudden cardiac death and pump failure death prediction in chronic heart failure by combining ECG and clinical markers in an integrated risk model.
    PLoS One. 2017;12:e0186152.
    PubMed     Abstract available


  329. MATONE A, Derlindati E, Marchetti L, Spigoni V, et al
    Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects.
    PLoS One. 2017;12:e0182559.
    PubMed     Abstract available


  330. BORNHEIMER R, Shea KM, Sato R, Weycker D, et al
    Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease.
    PLoS One. 2017;12:e0184877.
    PubMed     Abstract available


  331. KIM JS, Yang JW, Yoo JS, Choi SO, et al
    Association between E/e ratio and fluid overload in patients with predialysis chronic kidney disease.
    PLoS One. 2017;12:e0184764.
    PubMed     Abstract available


  332. BAKER J, White N, Mengersen K, Rolfe M, et al
    Joint modelling of potentially avoidable hospitalisation for five diseases accounting for spatiotemporal effects: A case study in New South Wales, Australia.
    PLoS One. 2017;12:e0183653.
    PubMed     Abstract available


  333. YAGYU T, Kumada M, Nakagawa T
    Novel risk stratification with time course assessment of in-hospital mortality in patients with acute heart failure.
    PLoS One. 2017;12:e0187410.
    PubMed     Abstract available


  334. SILVA FH, Veiga FJR, Mora AG, Heck RS, et al
    A novel experimental model of erectile dysfunction in rats with heart failure using volume overload.
    PLoS One. 2017;12:e0187083.
    PubMed     Abstract available


  335. MORA MT, Ferrero JM, Romero L, Trenor B, et al
    Sensitivity analysis revealing the effect of modulating ionic mechanisms on calcium dynamics in simulated human heart failure.
    PLoS One. 2017;12:e0187739.
    PubMed     Abstract available


  336. PFISTER R, Ihle P, Mews B, Kohnen E, et al
    Feasibility of including patients with migration background in a structured heart failure management programme: A prospective case-control study exemplarily on Turkish migrants.
    PLoS One. 2017;12:e0187358.
    PubMed     Abstract available


  337. GORODESKI EZ, Joyce E, Gandesbery BT, Blackstone EH, et al
    Discordance between 'actual' and 'scheduled' check-in times at a heart failure clinic.
    PLoS One. 2017;12:e0187849.
    PubMed     Abstract available


  338. XIA T, Chai X, Shen J
    Pancreatic exocrine insufficiency in patients with chronic heart failure and its possible association with appetite loss.
    PLoS One. 2017;12:e0187804.
    PubMed     Abstract available


  339. SAVIRA F, Cao L, Wang I, Yang W, et al
    Apoptosis signal-regulating kinase 1 inhibition attenuates cardiac hypertrophy and cardiorenal fibrosis induced by uremic toxins: Implications for cardiorenal syndrome.
    PLoS One. 2017;12:e0187459.
    PubMed     Abstract available


  340. GHITH N, Frolich A, Merlo J
    The role of the clinical departments for understanding patient heterogeneity in one-year mortality after a diagnosis of heart failure: A multilevel analysis of individual heterogeneity for profiling provider outcomes.
    PLoS One. 2017;12:e0189050.
    PubMed     Abstract available


  341. YEH HM, Lin TT, Yeh CF, Huang HS, et al
    Biomarkers and echocardiography for evaluating the improvement of the ventricular diastolic function after surgical relief of hydronephrosis.
    PLoS One. 2017;12:e0188597.
    PubMed     Abstract available


  342. TRIPATHI R, Sullivan R, Fan TM, Wang D, et al
    Enhanced heart failure, mortality and renin activation in female mice with experimental dilated cardiomyopathy.
    PLoS One. 2017;12:e0189315.
    PubMed     Abstract available


  343. BONDAR G, Togashi R, Cadeiras M, Schaenman J, et al
    Association between preoperative peripheral blood mononuclear cell gene expression profiles, early postoperative organ function recovery potential and long-term survival in advanced heart failure patients undergoing mechanical circulatory support.
    PLoS One. 2017;12:e0189420.
    PubMed     Abstract available


  344. PRADO FP, Dos Santos DO, Blefari V, Silva CA, et al
    Early dystrophin loss is coincident with the transition of compensated cardiac hypertrophy to heart failure.
    PLoS One. 2017;12:e0189469.
    PubMed     Abstract available


  345. KIM SH, Kim HJ, Han S, Yoo BS, et al
    The limited prognostic role of echocardiograms in short-term follow-up after acute decompensated heart failure: An analysis of the Korean Heart Failure (KorHF) Registry.
    PLoS One. 2017;12:e0188938.
    PubMed     Abstract available


  346. BAUTERS C, Dubois E, Porouchani S, Saloux E, et al
    Long-term prognostic impact of left ventricular remodeling after a first myocardial infarction in modern clinical practice.
    PLoS One. 2017;12:e0188884.
    PubMed     Abstract available


  347. KLAUKE B, Gaertner-Rommel A, Schulz U, Kassner A, et al
    High proportion of genetic cases in patients with advanced cardiomyopathy including a novel homozygous Plakophilin 2-gene mutation.
    PLoS One. 2017;12:e0189489.
    PubMed     Abstract available


    January 2016
  348. HSIAO SH, Chiou KR
    Diastolic Heart Failure Predicted by Left Atrial Expansion Index in Patients with Severe Diastolic Dysfunction.
    PLoS One. 2016;11:e0162599.
    PubMed     Abstract available


  349. CHA YS, Lee KH, Lee JW, Kwon W, et al
    The Usefulness of the Delta Neutrophil Index for Predicting Superimposed Pneumonia in Patients with Acute Decompensated Heart Failure in the Emergency Department.
    PLoS One. 2016;11:e0163461.
    PubMed     Abstract available


  350. NELVEG-KRISTENSEN KE, Bie P, Ferrero L, Bjerre D, et al
    Pharmacodynamic Impact of Carboxylesterase 1 Gene Variants in Patients with Congestive Heart Failure Treated with Angiotensin-Converting Enzyme Inhibitors.
    PLoS One. 2016;11:e0163341.
    PubMed     Abstract available


  351. KRUMHOLZ HM, Hsieh A, Dreyer RP, Welsh J, et al
    Trajectories of Risk for Specific Readmission Diagnoses after Hospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia.
    PLoS One. 2016;11:e0160492.
    PubMed     Abstract available


  352. DUFLOS CM, Solecki K, Papinaud L, Georgescu V, et al
    The Intensity of Primary Care for Heart Failure Patients: A Determinant of Readmissions? The CarPaths Study: A French Region-Wide Analysis.
    PLoS One. 2016;11:e0163268.
    PubMed     Abstract available


  353. SHINODA Y, Tagashira H, Bhuiyan MS, Hasegawa H, et al
    Corticosteroids Mediate Heart Failure-Induced Depression through Reduced sigma1-Receptor Expression.
    PLoS One. 2016;11:e0163992.
    PubMed     Abstract available


  354. ZITTERMANN A, Ernst JB, Pilz S, Dreier J, et al
    Calciotropic and Phosphaturic Hormones in End-Stage Heart Failure Patients Supported by a Left-Ventricular Assist Device.
    PLoS One. 2016;11:e0164459.
    PubMed     Abstract available


  355. ABBASI SA, Shah RV, McNulty SE, Hernandez AF, et al
    Left Atrial Structure and Function in Heart Failure with Preserved Ejection Fraction: A RELAX Substudy.
    PLoS One. 2016;11:e0164914.
    PubMed     Abstract available


  356. NAGAI T, Honda Y, Sugano Y, Nishimura K, et al
    Circulating Omega-6, But Not Omega-3 Polyunsaturated Fatty Acids, Are Associated with Clinical Outcomes in Patients with Acute Decompensated Heart Failure.
    PLoS One. 2016;11:e0165841.
    PubMed     Abstract available


  357. CHEN W, Zheng L, Li K, Wang Q, et al
    A Novel and Effective Method for Congestive Heart Failure Detection and Quantification Using Dynamic Heart Rate Variability Measurement.
    PLoS One. 2016;11:e0165304.
    PubMed     Abstract available


  358. YOKOTA J, Ogawa Y, Yamanaka S, Takahashi Y, et al
    Cognitive Dysfunction and Malnutrition Are Independent Predictor of Dysphagia in Patients with Acute Exacerbation of Congestive Heart Failure.
    PLoS One. 2016;11:e0167326.
    PubMed     Abstract available


  359. YU J, Chen R, Tan Y, Wu J, et al
    Salvianolic Acid B Alleviates Heart Failure by Inactivating ERK1/2/GATA4 Signaling Pathway after Pressure Overload in Mice.
    PLoS One. 2016;11:e0166560.
    PubMed     Abstract available


  360. BRAGA LM, Prado GF, Umeda II, Kawauchi TS, et al
    Reproducibility for Heart Rate Variability Analysis during 6-Min Walk Test in Patients with Heart Failure and Agreement between Devices.
    PLoS One. 2016;11:e0167407.
    PubMed     Abstract available


  361. UEDA K, Kasao M, Shimamura M, Haruta H, et al
    Impact of Oral Treatment on Physical Function in Older Patients Hospitalized for Heart Failure: A Randomized Clinical Trial.
    PLoS One. 2016;11:e0167933.
    PubMed     Abstract available


  362. MARCONDES-BRAGA FG, Batista GL, Gutz IG, Saldiva PH, et al
    Impact of Exhaled Breath Acetone in the Prognosis of Patients with Heart Failure with Reduced Ejection Fraction (HFrEF). One Year of Clinical Follow-up.
    PLoS One. 2016;11:e0168790.
    PubMed     Abstract available


  363. KANEKO M, Hashikami K, Yamamoto S, Matsumoto H, et al
    Phospholamban Ablation Using CRISPR/Cas9 System Improves Mortality in a Murine Heart Failure Model.
    PLoS One. 2016;11:e0168486.
    PubMed     Abstract available


  364. HAI JJ, Chan PH, Chan YH, Fong CH, et al
    Prediction of Thromboembolic Events in Heart Failure Patients in Sinus Rhythm: The Hong Kong Heart Failure Registry.
    PLoS One. 2016;11:e0169095.
    PubMed     Abstract available


  365. SUGIMOTO K, Yoshihisa A, Nakazato K, Jin Y, et al
    Pulmonary Arterial Capacitance Predicts Cardiac Events in Pulmonary Hypertension Due to Left Heart Disease.
    PLoS One. 2016;11:e0165603.
    PubMed     Abstract available


  366. BING R, Chow V, Lau JK, Thomas L, et al
    Prevalence of Echocardiography Use in Patients Hospitalized with Confirmed Acute Pulmonary Embolism: A Real-World Observational Multicenter Study.
    PLoS One. 2016;11:e0168554.
    PubMed     Abstract available


  367. KOOPMAN C, Vaartjes I, van Dis I, Verschuren WM, et al
    Explaining the Decline in Coronary Heart Disease Mortality in the Netherlands between 1997 and 2007.
    PLoS One. 2016;11:e0166139.
    PubMed     Abstract available


  368. PEIYUAN H, Jingang Y, Haiyan X, Xiaojin G, et al
    The Comparison of the Outcomes between Primary PCI, Fibrinolysis, and No Reperfusion in Patients >/= 75 Years Old with ST-Segment Elevation Myocardial Infarction: Results from the Chinese Acute Myocardial Infarction (CAMI) Registry.
    PLoS One. 2016;11:e0165672.
    PubMed     Abstract available


  369. COOKE CR
    Risk of Death Influences Regional Variation in Intensive Care Unit Admission Rates among the Elderly in the United States.
    PLoS One. 2016;11:e0166933.
    PubMed     Abstract available


  370. LEE KF, Tsai YT, Lin CY, Hsieh CB, et al
    Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan.
    PLoS One. 2016;11:e0155602.
    PubMed     Abstract available


  371. WANG Q, Guo YZ, Zhang YT, Xue JJ, et al
    The Effects and Mechanism of Atorvastatin on Pulmonary Hypertension Due to Left Heart Disease.
    PLoS One. 2016;11:e0157171.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: